A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT06161584 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Apellis Pharmaceuticals, Inc.